Tag: STD diagnostics market trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the STD Diagnostics Market Size Changed, over the years?

Over the past few years, there has been robust growth in the size of the STD diagnostics market. The market is expected to expand from $9.93 billion in 2024 to $10.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The historical growth can be ascribed to factors such as trends in epidemiology, advancements in healthcare infrastructure, pharmaceutical breakthroughs, sexual education initiatives, and demographic transitions.

How Much Will the STD Diagnostics Market Be Worth in 2029?

In the forthcoming years, the STD diagnostics market is projected to experience robust growth, expanding to $16.21 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.5%. The surge during the forecast period can be linked to trends in personalized medicine, augmented accessibility to healthcare, public health strategies, telemedicine, and digital health, as well as an increase in STD occurrences. Key market trends anticipated during this period encompass advancements in point-of-care testing (POCT), the advent of home testing kits, multiplex testing, targeted marketing initiatives and outreach, the introduction of pre-exposure prophylaxis (prep) programs, among rising incidence rates.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Which is the Largest Company in the STD Diagnostics Market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

What Are the Main Market Drivers in the STD Diagnostics Industry?

The escalating incidents of sexually transmitted diseases (STDs) are the driving force behind the STD diagnostics market. STDs are communicable illnesses transferred through sexual relations from an infected individual to a healthy person. STD diagnostics offer proficient evaluation and testing for these infections. The World Health Organization (WHO), a global United Nations body aiming to enhance universal public health, revealed in 2022 that more than 1 million sexually-transmitted infections occur daily worldwide. Furthermore, about 374 million new cases annually are diagnosed with one out of four STDs, including chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the increasing occurrence of STDs is fueling the STD diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

How Is the STD Diagnostics Market Segments Structured?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

What Strategic Trends Are Transforming the STD Diagnostics Market?

The proliferation of STD diagnostics signifies a crucial trend in the STD diagnostic market. Major corporations are enhancing their testing amenities and strategies for a more efficient and expedited diagnosis of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the USA, unveiled a wholly automated, high-throughput infectious disease molecular diagnostics platform, coined as BD CORTM MX/PX System in May 2022. This platform consolidates and mechanizes the molecular laboratory procedure, spanning from sample processing to the delivery of diagnostic test results. The inaugural test accessible on this new platform is the BD CTGCTV2 molecular assay, a standalone test that can detect the top three non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the STD Diagnostics Market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

This Report Delivers Insight On:

1. How big is the std diagnostics market, and how is it changing globally?

2. Who are the major companies in the std diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the std diagnostics market right now?

4. Which products or customer segments are growing the most in the std diagnostics market?

5. What factors are helping or slowing down the growth of the std diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the STD Diagnostics Market Size Changed, over the years?

Over the past few years, there has been robust growth in the size of the STD diagnostics market. The market is expected to expand from $9.93 billion in 2024 to $10.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The historical growth can be ascribed to factors such as trends in epidemiology, advancements in healthcare infrastructure, pharmaceutical breakthroughs, sexual education initiatives, and demographic transitions.

How Much Will the STD Diagnostics Market Be Worth in 2029?

In the forthcoming years, the STD diagnostics market is projected to experience robust growth, expanding to $16.21 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.5%. The surge during the forecast period can be linked to trends in personalized medicine, augmented accessibility to healthcare, public health strategies, telemedicine, and digital health, as well as an increase in STD occurrences. Key market trends anticipated during this period encompass advancements in point-of-care testing (POCT), the advent of home testing kits, multiplex testing, targeted marketing initiatives and outreach, the introduction of pre-exposure prophylaxis (prep) programs, among rising incidence rates.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Which is the Largest Company in the STD Diagnostics Market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

What Are the Main Market Drivers in the STD Diagnostics Industry?

The escalating incidents of sexually transmitted diseases (STDs) are the driving force behind the STD diagnostics market. STDs are communicable illnesses transferred through sexual relations from an infected individual to a healthy person. STD diagnostics offer proficient evaluation and testing for these infections. The World Health Organization (WHO), a global United Nations body aiming to enhance universal public health, revealed in 2022 that more than 1 million sexually-transmitted infections occur daily worldwide. Furthermore, about 374 million new cases annually are diagnosed with one out of four STDs, including chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the increasing occurrence of STDs is fueling the STD diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

How Is the STD Diagnostics Market Segments Structured?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

What Strategic Trends Are Transforming the STD Diagnostics Market?

The proliferation of STD diagnostics signifies a crucial trend in the STD diagnostic market. Major corporations are enhancing their testing amenities and strategies for a more efficient and expedited diagnosis of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the USA, unveiled a wholly automated, high-throughput infectious disease molecular diagnostics platform, coined as BD CORTM MX/PX System in May 2022. This platform consolidates and mechanizes the molecular laboratory procedure, spanning from sample processing to the delivery of diagnostic test results. The inaugural test accessible on this new platform is the BD CTGCTV2 molecular assay, a standalone test that can detect the top three non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Global Regions Offer the Highest Growth in the STD Diagnostics Market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

This Report Delivers Insight On:

1. How big is the std diagnostics market, and how is it changing globally?

2. Who are the major companies in the std diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the std diagnostics market right now?

4. Which products or customer segments are growing the most in the std diagnostics market?

5. What factors are helping or slowing down the growth of the std diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the std diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the STD Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?

Over the past few years, the STD diagnostics market has seen significant growth. The market size is predicted to expand from $9.93 billion in 2024 to $10.86 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.4%. This growth during the historic period can be linked to factors such as epidemiological trends, development in healthcare infrastructure, advancements in pharmaceuticals, sex education programs, and demographic changes.

The market size of STD diagnostics is forecasted to undergo a significant surge in the upcoming years, expanding to a valuation of $16.21 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. This growth during the predicted period can be ascribed to factors like the emergence of personalized medicine, enhancements in healthcare accessibility, strategies for population health, the rise of telemedicine and digital health, and an upturn in the prevalence of STDs. Key trends to look out for in this forecasted period encompass advancements in point-of-care testing (POCT), the advent of home testing kits, the introduction of multiplex testing, targeted marketing and outreach strategies, preventative programs like pre-exposure prophylaxis (prep), and an escalation in incidence rates.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Which Primay Drivers Are Accelerating Growth in the STD Diagnostics Market?

The STD diagnostics market is being propelled forward by the increasing occurrence of sexually transmitted diseases (STDs). STDs are infectious conditions that spread from an infected individual to an uninfected one via sexual interaction. STD diagnostics offer effective examination and verification of these infections. For example, the World Health Organization (WHO) – a United Nations body aimed at enhancing global public health, reported in 2022, over 1 million sexually transmitted infections are contracted globally every day. Further, there are approximately 374 million fresh infections annually, with one in four STDs including chlamydia, gonorrhea, syphilis, and trichomoniasis. Therefore, as the prevalence of STDs escalates, so does the growth of the STD diagnostics market.

Which Primary Segments of the STD Diagnostics Market Are Driving Growth and Industry Transformations?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

Which Regions Are Key Players in the Growth of the STD Diagnostics Market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the STD Diagnostics Industry Dynamics?

The development in STD diagnostics is a crucial trend in the STD diagnostic market. Reputed players are enhancing their testing facilities and strategies to offer improved and quicker detection of sexually transmitted diseases. To illustrate, in May 2022, BD (Becton, Dickinson, and Company), an American medical technology enterprise, unveiled a fully automatic, high-capacity platform for infectious disease molecular diagnostics, dubbed as the BD CORTM MX/PX System. This platform brings together and streamlines the molecular lab operations, starting from sample handling to the production of diagnostic test results. The first test that became available on this new platform is the BD CTGCTV2 molecular assay, a sole test capable of detecting the top three most common non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

View the full report here:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

What Parameters Are Used to Define the STD Diagnostics Market?

STDs (sexually transmitted diseases) diagnostics refers to analyzing and identifying infectious illnesses spread by sexual contact from an infected person to a healthy person. STD diagnostics are used to detect whether an individual has been infected with sexually transmitted diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theSTD Diagnostics Market?

The proliferation of sexually transmitted diseases (STDs) is propelling the growth of the STD diagnostics market. STDs, which are infectious diseases passed from an infected individual to a healthy one through sexual contact, are effectively analyzed and tested thanks to STD diagnostics. For instance, the World Health Organization (WHO), a United Nations institution focused on bettering global public health, reported in 2022 that over a million sexually transmitted infections are contracted every day around the world. Moreover, an estimated 374 million new infections occur annually, with one out of every four being STDs such as chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the escalating incidence of STDs fuels the STD diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

#How Does the ProjectedSTD Diagnostics Market Growth Compare Over the Forecast Period?

In the past few years, there has been a significant expansion in the size of the STD diagnostics market. Its growth is projected to increase from $9.93 billion in 2024 to $10.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The surge in growth during the historical period can be traced back to factors such as epidemiological patterns, advancements in healthcare infrastructure, developments in the pharmaceutical sector, programs aimed at sexual education, and demographic changes.

The market size for STD diagnostics is predicted to expand significantly in the coming years, reaching a value of $16.21 billion in 2029, with a compound annual growth rate (CAGR) of 10.5%. Key drivers for growth during the forecasted period include emerging trends in personalized medicine, enhanced healthcare access, strategies focussed on population health, advancements in telemedicine and digital health, along with an increase in STD occurrences. The forecast period is also expected to see major trends such as advancements in point-of-care testing (POCT), the popularity of home testing kits, multiplex testing, targeted marketing and outreach, programs focused on pre-exposure prophylaxis (prep), and rising incidence rates.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

What Are the Latest Innovations Influencing theSTD Diagnostics Market?

Progress in STD diagnostics is a significant trend in the STD diagnostic market. Major market participants are enhancing their testing facilities and methods to offer a superior and quicker diagnosis of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the US, introduced a fully automated high-capacity molecular diagnostic platform for infectious diseases named BD CORTM MX/PX System in May 2022. This platform streamlines and automates the molecular lab process, ranging from sample handling to the delivery of diagnostic test results. The initial test available on this new platform is the BD CTGCTV2 molecular assay, designed to detect the three most common non-viral sexually transmitted infections – Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Who Are the Major Industry Players Accelerating Growth in theSTD Diagnostics Market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Primary Segments of the STD Diagnostics Market Are Driving Growth and Industry Transformations?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8507&type=smpGlobal STD Diagnostics Market, Global STD Diagnostics Market Report, Global STD Diagnostics Market Trends, Global STD Diagnostics Market Size

Browse Through More Reports Similar to the Gobal STD Diagnostics Maret 2025, By The Business Research Company:

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Molecular Diagnostics Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the std diagnostics market?

The market for STD diagnostics has seen significant expansion in the past few years. The growth is expected to continue, as it’s projected to increase from $9.93 billion in 2024 to $10.86 billion in 2025, representing a compound annual growth rate (CAGR) of 9.4%. This growth during the historical period is due mainly to factors such as epidemiological trends, advancements in healthcare infrastructure, developments in the pharmaceutical sector, sexual education initiatives, and demographic changes.

What will be the std diagnostics market size in the future?

Rapid expansion is anticipated in the STD diagnostics market size over the next few years, with a predicted growth to $16.21 billion in 2029 and a compound annual growth rate (CAGR) of 10.5%. Factors encouraging the growth in the forecasted period include the trend of personalized medicine, advancements in healthcare accessibility, population health initiatives, the evolution of telemedicine and digital health, and an increase in STD incidences. Key trends on the horizon within the forecast period involve progress in point-of-care testing (POCT), the advancement of home testing kits, multiplex trials, targeted marketing campaigns and outreach, initiation of pre-exposure prophylaxis (prep) programs, and climbing incidence rates.

Get your std diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

What main drivers are fueling expansion in the std diagnostics market?

The expanding incidence of sexually transmitted diseases (STDs) is propelling the STD diagnostics market. STDs are infections that are transmitted from a person carrying the disease to a healthy person via sexual activity. STD diagnostics facilitate the effective detection and analysis of such diseases. As per a 2022 report by the World Health Organization (WHO), an international institution of the United Nations aimed at global public health enhancement, there are over 1 million new sexually transmitted infections globally each day. Furthermore, annually, there are roughly 374 million fresh cases of 1 of 4 STDs namely, chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the increasing STD cases bolster the STD diagnostics market.

What key areas define the segmentation of the global std diagnostics market?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Who are the dominant players expanding their reach in the std diagnostics market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

How are evolving market trends shaping std diagnostics Strategies?

The progression in the field of STD diagnostics is a significant trend within the STD diagnostic market. Prominent industry players are enhancing their diagnostic facilities and methods to facilitate more efficient and quicker detection of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the US, introduced a fully automated infectious disease molecular diagnostics platform in May 2022. This platform, known as the BD CORTM MX/PX System, merges and automates the molecular laboratory process, from sample handling to the delivery of diagnostic test results. The initial test available on this new system is the BD CTGCTV2 molecular assay. This single test can detect the top three non-viral sexually transmitted infections: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

Which regions are emerging as leaders in the std diagnostics market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Molecular Diagnostics Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the STD Diagnostics Market from 2025 to 2034, and What Factors Influence It?

The market size for STD diagnostics has seen significant growth in the past few years. It is projected to expand from $9.93 billion in 2024 to $10.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this past growth include epidemiological trends, enhancements in healthcare infrastructure, advancements in pharmaceuticals, sexual education initiatives, and demographic changes.

In the coming years, a swift expansion is anticipated in the STD diagnostics market size, with projections indicating it will reach $16.21 billion by 2029, displaying a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period can be ascribed to the emergence of personalized medicine, advancements in healthcare access, strategies focusing on population health, telemedicine, and digital health aspects, as well as an increased occurrence of STDs. The forecast period is expected to witness major trends like the progression of point-of-care testing (POCT), the introduction of home testing kits, the advent of multiplex testing, targeted marketing and outreach programs, pre-exposure prophylaxis (prep) programs, along with escalating incidence rates.

Which Drivers Are Expected to Have the Greatest Impact on the std diagnostics Market’s Growth?

The STD diagnostics market is being propelled by the increasing incidence of sexually transmitted diseases (STDs). STDs, which are infectious diseases passed on from one individual to another through sexual activity, can be effectively tested and diagnosed using STD diagnostics. For example, the World Health Organization (WHO), a United Nations agency dedicated to enhancing global public health, reported in 2022 that over 1 million sexually transmitted infections are contracted daily worldwide. Furthermore, around 374 million new infections occur yearly, with chlamydia, gonorrhea, syphilis, and trichomoniasis accounting for one out of every four STDs. This increasing prevalence of STDs, therefore, is fueling growth in the STD diagnostics market.

Get Your Free Sample of the Global STD Diagnostics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Who Are the Leading Players Fueling Growth in the STD Diagnostics Market?

Major companies operating in the STD diagnostics market are:

• Siemens AG_x000D_

• Abbott Laboratories_x000D_

• Qiagen Inc._x000D_

• Danaher Corporation_x000D_

• F. Hoffmann-La Roche AG_x000D_

What Are the Emerging Trends Shaping the Future of the STD Diagnostics Market?

The significant innovations in STD testing mark a prevalent trend in the STD diagnostic market. Prominent industry stakeholders are enhancing their facilities and methodologies for improved and quicker detection of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a leading medical technology firm based in the USA, launched an all-in-one, high-capacity infectious disease molecular diagnostics system, called BD CORTM MX/PX System, in May 2022. This system integrates and streamlines the molecular lab procedures, starting from sample processing up to the delivery of diagnostic test results. The BD CTGCTV2 molecular assay is the first test available on this brand-new platform, and it is a singular test capable of identifying the top three most prevalent non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Get Instant Access to the Global STD Diagnostics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the STD Diagnostics Market?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

Which Regions Are Driving Growth in the STD Diagnostics Market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the STD Diagnostics Market?

STDs (sexually transmitted diseases) diagnostics refers to analyzing and identifying infectious illnesses spread by sexual contact from an infected person to a healthy person. STD diagnostics are used to detect whether an individual has been infected with sexually transmitted diseases.

Browse Through More Similar Reports By The Business Research Company:

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Molecular Diagnostics Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: